This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Stephens, J. W Articles by Hurel, S. J Search for Related Content Social Bookmarking                         What's this?

What are the clinical manifestations of cardiovascular disease in diabetes? Ten year analysis from a clinic based population

Department of Diabetes & Endocrinology, UCL Hospitals, Mortimer Street, London, W1T 3AA, UK, rmhajst{at}ucl.ac.uk, Centre for Cardiovascular Genetics, Department of Medicine, University College London, 5 University Street, London, W1CE 6JF, UK

Steve E Humphries

Centre for Cardiovascular Genetics, Department of Medicine, University College London, 5 University Street, London, W1CE 6JF, UK

Jacqueline A Cooper

Centre for Cardiovascular Genetics, Department of Medicine, University College London, 5 University Street, London, W1CE 6JF, UK

Steven J Hurel

Department of Diabetes & Endocrinology, UCL Hospitals, Mortimer Street, London, W1T 3AA, UK

Aims

Cardiovascular disease may manifest as CHD, PVD and CbVD. Our aim was to explore these interactions and associated risk factors.

Methods

Patients were identified who attended clinic in 1990—1991 and remained under follow-up in 2000—2001. The latter were categorised by the presence/absence of manifest CHD, PVD and CbVD. Baseline clinic measurements (1990—1991) were studied in relation to CVD manifestations.

Results

Seven hundred and ninety-eight (CVD:358) patients were identified with follow-up. Of those with CVD: 51% had CHD, 14% PVD, and 9% CbVD exclusively. A further 17% had CHD+PVD, 4% CHD+CbVD, 2% PVD+CbVD, while 3% of patients had all three manifestations together. Increasing age, LDL-cholesterol and glucose were associated with increased risk of CHD, PVD and CbVD.

Conclusions

The majority of diabetic patients with CVD have $CHD (75%), and only 3% have a combination of CHD, PVD and CbVD.

Key Words: cardiovascular disease • coronary heart disease • peripheral vascular disease • diabetes • risk factors.

References

• Orchard T. Diabetes: a time for excitement-and concern. BMJ 1998;317:691-2.[Free Full Text]
• Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic Med 1997;14(suppl 5):S1-S85.[Medline] [Order article via Infotrieve]
• Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S., Kannel WB Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 1986;256:2835-8.[Abstract/Free Full Text]
• Garcia MJ, McNamara PM, Gordon T., Kannell WB Morbidity and mortality in diabetes in the Framingham population. Sixteen-year follow-up. Diabetes 1974;23:105-11.[Web of Science][Medline] [Order article via Infotrieve]
• Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987;30:123-31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Stamler J., Vaccaro N., Neaton J., Wentworth D. for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors and 12year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;15:434-44.
• American Diabetes Association. Consensus statement: Role of the cardiovascular risk factors in the prevention and treatment of macrovascular disease in diabetes. Diabetes Care 1989;12:573-9.[Web of Science][Medline] [Order article via Infotrieve]
• Goraya TY, Leibson CL, Palumbo PJ et al. Coronary atherosclerosis in diabetes mellitus-a population-based autopsy study. J Am Coll Cardiol 2002; 40:946-53.[Abstract/Free Full Text]
• CAPRIE Steering Committee. A randomised, blinded, trial of clopidrogel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ness J., Aronow WS Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1999;47:1255-6.[Web of Science][Medline] [Order article via Infotrieve]
• Ness J., Aronow WS, Ahn C. Prevalence of coronary artery disease, ischemic stroke, and symptomatic peripheral arterial disease and of associated risk factors in older men and women with and without diabetes mellitus. Prev Cardiol 2000;4:160-2.
• Ness J., Aronow WS Prevalence of coronary artery disease, ischemic stroke, peripheral arterial disease, and coronary revascularisation in older African-American, Asians, Hispanics, Whites, Men, and Women. Am J Cardiol 1999;84:932-3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Turner RC, Millns H., Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-8.[Abstract/Free Full Text]
• Bastyr EJ, Stuart CA, Brodows RG et al. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HBA1c. Diabetes Care 2000;23:1236-41.[Abstract/Free Full Text]
• The DECODE study group on behalf of the European Diabetes Epedemiology Group. Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-h diagnostic criteria. Arch Intern Med 2001;161:397-404.[Abstract/Free Full Text]
• Bonora E., Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 2001;44:2017-114.
• Struthers AD, Morris AD Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 2002;359:1430-2.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hobbs FDR, Davis RC, Roalfe AK, Hare R., Davies MK, Kenkre JE Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002;324:1-5.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 3, 190-194 (2004)
DOI: 10.1177/14746514040040030801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Stephens, J. W Articles by Hurel, S. J Search for Related Content Social Bookmarking                         What's this?